Advocacy is one of the three pillars of ASRA's mission. ASRA addresses this core purpose by advocating at the regulatory level in the best interest of our members and the patients they serve. (Note: ASRA does not participate in legislative advocacy or lobbying.)

ASRA is a member  of the U.S. Food and Drug Administration (FDA) Network of Experts, a program for efficiently exchanging information and knowledge in emerging fields of science and pioneering technologies, including regional anesthesia and pain medicine, to further goals of having more innovative, safe, and effective regional anesthesia and pain medicine medical products on the market.

ASRA and the American Society of Anesthesiologists have partnered to create an ASRA/ASA Ad Hoc Working Group on Substance Use Disorder (SUD). The group includes representation from the American Academy of Pain Medicine, American Society of Addiction Medicine, and the American Society of Health-System Pharmacists. Read more here.

Advocacy news items

ASRA positions

Health policy resources

How Does MACRA Affect Medicare Payments to Physicians?

MACRA: Frequently Asked Questions

MACRA: New Opportunities For Medicare Providers Through Innovative Payment Systems (external link)

Medicare Evaluation and Management (E/M) Code Payment and Documentation Requirements Changes

Medicare Payment for Clinic Visits Furnished in Off-Campus Hospital Provider-Based Departments Reduced to $81 Beginning CY 2019

MIPS Fact Sheet: Chronic Pain (PDF)

MIPS Fact Sheet: Regional Anesthesia and Acute Pain (PDF)

The Merit-Based Incentive Payment System (MIPS) & Alternative Payment Models (APMs): Delivery System, Reform, Medicare Payment Reform, and MACRA (external link)